Oral therapies for multiple sclerosis: are we there yet?
Lancet Neurol
.
2010 May;9(5):454-7.
doi: 10.1016/S1474-4422(10)70088-0.
Authors
Hans-Peter Hartung
,
Orhan Aktas
PMID:
20398852
DOI:
10.1016/S1474-4422(10)70088-0
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Clinical Trials as Topic
Humans
Multiple Sclerosis / drug therapy*